BiondVax signs exclusive license agreement for development and commercialization of a novel anti-IL-17 antibody for treatment of autoimmune and inflammatory diseases including psoriasis
Stock Information for Scinai Immunotherapeutics Ltd Sponsed ADR (New)
Loading
Please wait while we load your information from QuoteMedia.